Recent Quarter Total Invested
$6.54 B
Recent Quarter Institutional Ownership Percentage
0.1%
Total Invested of Last Quarter
$5.12 B
Ownership Percentage of Last Quarter
0.1%
Revolution Medicines, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 08/13/2024 | 14.38 M | $558.02 M | -2.57% | 0.01% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 13.66 M | $530.15 M | -7.17% | 0.01% |
BLACKROCK INC. | 08/13/2024 | 13.41 M | $520.39 M | 8.94% | 0.01% |
FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 9.76 M | $378.70 M | 29.97% | 0.01% |
BAKER BROS. ADVISORS LP | 08/14/2024 | 7.57 M | $293.76 M | 0.26% | 0.00% |
NEXTECH INVEST LTD. | 08/14/2024 | 6.30 M | $244.38 M | 0.00% | 0.00% |
BVF INC/IL | 08/14/2024 | 5.98 M | $232.13 M | 0.00% | 0.00% |
FMR LLC | 08/13/2024 | 5.63 M | $218.34 M | 35.02% | 0.00% |
ALPHABET INC. | 08/02/2024 | 5.31 M | $205.97 M | 0.10% | 0.00% |
PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 5.26 M | $204.11 M | 80.42% | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 5.22 M | $202.46 M | 8.36% | 0.00% |
STATE STREET CORP | 08/14/2024 | 5.07 M | $196.81 M | -5.85% | 0.00% |
BELLEVUE GROUP AG | 08/14/2024 | 5.03 M | $195.18 M | -0.88% | 0.00% |
JANUS HENDERSON GROUP PLC | 08/14/2024 | 4.64 M | $180.07 M | 18.61% | 0.00% |
CASDIN CAPITAL, LLC | 10/18/2024 | 4.41 M | $171.03 M | -21.55% | 0.00% |
BOXER CAPITAL, LLC | 08/14/2024 | 4.28 M | $166.09 M | 0.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 3.34 M | $129.48 M | 9.27% | 0.00% |
WOODLINE PARTNERS LP | 08/14/2024 | 3.29 M | $127.72 M | -13.34% | 0.00% |
JPMORGAN CHASE & CO | 08/12/2024 | 3.12 M | $120.92 M | -11.21% | 0.00% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 3.09 M | $119.93 M | 0.00% | 0.00% |
AH CAPITAL MANAGEMENT, L.L.C. | 08/13/2024 | 2.75 M | $106.67 M | 0.00% | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 2.36 M | $91.73 M | 42.82% | 0.00% |
HOLOCENE ADVISORS, LP | 08/14/2024 | 2.20 M | $85.52 M | -9.04% | 0.00% |
NORGES BANK | 08/14/2024 | 1.85 M | $71.75 M | 100.00% | 0.00% |
AMERIPRISE FINANCIAL INC | 08/14/2024 | 1.47 M | $57.14 M | -13.11% | 0.00% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.45 M | $56.20 M | 28.90% | 0.00% |
LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 1.20 M | $46.57 M | 100.00% | 0.00% |
NORTHERN TRUST CORP | 08/14/2024 | 1.18 M | $45.80 M | -2.82% | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 1.11 M | $43.07 M | 5.46% | 0.00% |
ARTAL GROUP S.A. | 08/14/2024 | 1.02 M | $39.42 M | -22.97% | 0.00% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 997,455 | $38.71 M | 0.00% | 0.00% |
MORGAN STANLEY | 10/17/2024 | 995,489 | $38.63 M | 7.38% | 0.00% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 943,195 | $36.61 M | 2.11% | 0.00% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2024 | 914,003 | $35.47 M | 100.00% | 0.00% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 856,178 | $33.23 M | 17.49% | 0.00% |
MARSHALL WACE, LLP | 08/14/2024 | 816,055 | $31.67 M | -46.87% | 0.00% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 755,000 | $29.30 M | 18.90% | 0.00% |
FINEPOINT CAPITAL LP | 08/13/2024 | 729,464 | $28.31 M | 7.73% | 0.00% |
EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 650,826 | $25.26 M | 80.28% | 0.00% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 645,253 | $25.04 M | 21.88% | 0.00% |
CANDRIAM S.C.A. | 08/05/2024 | 554,334 | $21.51 M | -5.07% | 0.00% |
VICTORY CAPITAL MANAGEMENT INC | 08/05/2024 | 542,601 | $21.06 M | -9.65% | 0.00% |
AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 519,305 | $20.15 M | 100.00% | 0.00% |
DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 511,894 | $19.87 M | 0.00% | 0.00% |
MIC CAPITAL MANAGEMENT UK LLP | 08/14/2024 | 508,569 | $19.74 M | 0.00% | 0.00% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 455,132 | $17.66 M | 21.77% | 0.00% |
SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 455,099 | $17.66 M | 100.00% | 0.00% |
CITADEL ADVISORS LLC | 08/14/2024 | 408,842 | $15.87 M | -30.48% | 0.00% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 400,567 | $15.55 M | -26.38% | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 390,583 | $15.16 M | -70.66% | 0.00% |
Revolution Medicines, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of RVMD shares?
During the previous two years, 217 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:
INNEALTA CAPITAL, LLC: 0
VANGUARD GROUP INC: 14.38 M
WELLINGTON MANAGEMENT GROUP LLP: 13.66 M
BlackRock Inc.: 13.41 M
FARALLON CAPITAL MANAGEMENT LLC: 9.76 M
BAKER BROS. ADVISORS LP: 7.57 M
-
What percentage of Revolution Medicines, Inc. stock is owned by institutional investors?
0.10% of Revolution Medicines, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at RVMD ?
Institutional investors have bought a total of 176.80 M shares in the last 24 months. This purchase volume represents approximately $9.88 B in transactions.